77 related articles for article (PubMed ID: 26209720)
1. Ubiquitin-specific protease 28 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity by regulating MYC expression.
Wang Z; Song Q; Xue J; Zhao Y; Qin S
Exp Biol Med (Maywood); 2016 Feb; 241(3):255-64. PubMed ID: 26209720
[TBL] [Abstract][Full Text] [Related]
2. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage.
Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N
Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944
[TBL] [Abstract][Full Text] [Related]
3. USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells.
Karapurkar JK; Colaco JC; Suresh B; Tyagi A; Woo SH; Jo WJ; Ko N; Singh V; Hong SH; Oh SJ; Kim KS; Ramakrishna S
Cell Mol Life Sci; 2024 Mar; 81(1):145. PubMed ID: 38498222
[TBL] [Abstract][Full Text] [Related]
4. Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells.
Prieto-Garcia C; Hartmann O; Reissland M; Braun F; Fischer T; Walz S; Schülein-Völk C; Eilers U; Ade CP; Calzado MA; Orian A; Maric HM; Münch C; Rosenfeldt M; Eilers M; Diefenbacher ME
EMBO Mol Med; 2020 Apr; 12(4):e11101. PubMed ID: 32128997
[TBL] [Abstract][Full Text] [Related]
5. Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia.
Xu J; Peng J; Sun S; Wang D; Yuan W; Yang X; Shi T; Wang R; Liu H; Zhang P; Zhu HH
Br J Haematol; 2024 Apr; ():. PubMed ID: 38685813
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the bi-specificity of USP25 and USP28 inhibitors.
Patzke JV; Sauer F; Nair RK; Endres E; Proschak E; Hernandez-Olmos V; Sotriffer C; Kisker C
EMBO Rep; 2024 May; ():. PubMed ID: 38816515
[TBL] [Abstract][Full Text] [Related]
7. Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance.
Cremona CA; Sancho R; Diefenbacher ME; Behrens A
Semin Cancer Biol; 2016 Feb; 36():52-61. PubMed ID: 26410034
[TBL] [Abstract][Full Text] [Related]
8. Putative role of SUMOylation in controlling the activity of deubiquitinating enzymes in cancer.
Masoumi KC; Marfany G; Wu Y; Massoumi R
Future Oncol; 2016 Feb; 12(4):565-74. PubMed ID: 26777062
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal ubiquitin-binding region of ubiquitin-specific protease 28 modulates its deubiquitination function: NMR structural and mechanistic insights.
Wen Y; Shi L; Ding Y; Cui R; He WT; Hu HY; Zhang N
Biochem J; 2015 Oct; 471(2):155-65. PubMed ID: 26268556
[TBL] [Abstract][Full Text] [Related]
10. Fbw7 and Usp28 - enemies and allies.
Taranets L; Zhu J; Xu W; Popov N
Mol Cell Oncol; 2015; 2(3):e995041. PubMed ID: 27308481
[TBL] [Abstract][Full Text] [Related]
11. BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.
Li YY; Wu C; Chen SM; Shah SS; Wangpaichitr M; Feun LG; Kuo MT; Suarez M; Prince J; Savaraj N
Oncotarget; 2016 Apr; 7(14):17665-80. PubMed ID: 26771234
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine inhibits the proliferation and induces the differentiation of glioma stem-like cells through modulating the Wnt signaling pathway in vitro.
Guo QH; Yang HJ; Wang SD
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2406-15. PubMed ID: 26214776
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating c-Myc: USP36 steps up in the nucleolus.
Sun XX; Sears RC; Dai MS
Cell Cycle; 2015; 14(24):3786-93. PubMed ID: 26697836
[TBL] [Abstract][Full Text] [Related]
14. Targeting deubiquitinase USP28 for cancer therapy.
Wang X; Liu Z; Zhang L; Yang Z; Chen X; Luo J; Zhou Z; Mei X; Yu X; Shao Z; Feng Y; Fu S; Zhang Z; Wei D; Jia L; Ma J; Guo X
Cell Death Dis; 2018 Feb; 9(2):186. PubMed ID: 29415985
[TBL] [Abstract][Full Text] [Related]
15. USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer.
Dong Z; Guo S; Wang Y; Zhang J; Luo H; Zheng G; Yang D; Zhang T; Yan L; Song L; Liu K; Sun Z; Meng X; Zheng Z; Zhang J; Zhao Y
Onco Targets Ther; 2020; 13():8495-8510. PubMed ID: 32904569
[TBL] [Abstract][Full Text] [Related]
16. The deubiquitinase USP34 stabilizes SOX2 and induces cell survival and drug resistance in laryngeal squamous cell carcinoma.
Dai WL; Yuan SX; Cao JP
Kaohsiung J Med Sci; 2020 Dec; 36(12):983-989. PubMed ID: 32783291
[TBL] [Abstract][Full Text] [Related]
17. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
18. Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression.
Luo Y; Tian Z; Hua X; Huang M; Xu J; Li J; Huang H; Cohen M; Huang C
Cell Mol Life Sci; 2020 Jan; 77(2):351-363. PubMed ID: 31222373
[TBL] [Abstract][Full Text] [Related]
19. The
Thayer JA; Awad O; Hegdekar N; Sarkar C; Tesfay H; Burt C; Zeng X; Feldman RA; Lipinski MM
Autophagy; 2020 Jan; 16(1):140-153. PubMed ID: 30957634
[TBL] [Abstract][Full Text] [Related]
20. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.
Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D
Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
